VIRAL LOAD MONITORING AND FIBRINOLYTIC MARKERS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY
Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2018, Vol 5, Issue 12
Abstract
A study on Viral Load Monitoring and fibrinolytic markers in Human Immunodeficiency Virus patients on Antiretroviral Therapy (ART) was carried out to monitor the effect of therapy on these parameters. The study was carried out in three phases: Baseline sample collection, samples taken after three months of follow-up and samples taken after six months of follow-up with antiretroviral therapy. A total of forty (40) Antiretroviral therapy naive patients, of which 14 and 26 were males and females; age range of 20-45 years attending Rivers State University Teaching Hospital, Port Harcourt, were monitored for their viral load and fibrinolytic markers, within a follow up period of 6 months which included baseline, three months and six months. Viral load was determined using real time PCR and Enzyme Linked Immunosorbent Assay Technique were used for fibrinolytic markers. Data and statistical analysis were performed using S 9.4 Statistical analysis software (SAS Institute, Cary, NC, USA). P-value < 0.05 was recorded as significant for viral load, tissue plasminogen activator (tPA) and D-Dimer. Baseline viral load was 21476 ± 56914 cp/ml, after 3 month of ART it was 706 ± 108 cp/ml and 4-6 months of follow-up to 30 ± 3 cp/ml for a total of 100% overall decrease from baseline at the end of 6 months of follow-up. tPA increased 89% from baseline of 64.45 ± 6.85 ng/ml to 121.76 ± 6.64 ng/ml after 3 months of follow-up, but subsequently decreased by 45% to 67.38 ± 1.94 ng/ml between 4-6 months with a positive status of 3% increase attained at the end of 6 months from baseline. D-Dimer initially decreased sharply by 89% to 242.74 ± 52.87 pg/ml after 3 months follow-up from the mean baseline value of 2282.74 ± 325.68 pg/ml. This was followed by sharp and sudden increase of 462% increase to 1363.12 ± 209.14 pg/ml during the period between 4-6 months, with a resultant overall increase of 40% at the end of 6 months follow-up (Baseline-6 months). However, and Plasminogen activator inhibitor – 1 was low at baseline 10.84 ± 0.48 ng/ml with a significant elevation to 45.45 ± 3.47 ng/ml at 3 months of treatment and further increased to 77.56 ± 1.62 ng/ml at the end of 6 months. The findings from this study show that ART has an influence on the levels of tPA which may lead to a prothrombotic state in HIV on treatment.
Authors and Affiliations
Dr. Moore-Igwe B. W.
Keywords
Related Articles
- EP ID EP639958
- DOI -
- Views 131
- Downloads 0
FAST DISSOLVING ORAL FILM: OVERVIEW
The purpose of the current review is to enlighten the present and the future prospective on oral fast dissolving films (OFDFs) as a drug delivery system as they are gaining interest as a substitute of fast dissolving tab...
AN INSIGHT INTO TOBACCO USE AND CONTROL IN INDIA FROM THE PAST TO THE PRESENT
Tobacco smoke is harmful not only to smokers but to non-smokers as well. Smoking cigarette and other tobacco products impose a large and growing global public health burden. Responsible for almost 5 billion deaths per ye...
ASSESSEMENT OF SOME CYTOKINES IN PREGNANCY LOSS
Background: Human pregnancy is mediated by complex immunological alterations. Objective: Assessment of some cytokines in pregnancy loss in Abia State, South East, Nigeria. Materials and Methods: This was a cross-sectiona...
ASSESSMENT OF THE LEVELS OF TISSUE NECROTIC FACTOR – ALPHA (TNF-Α) AND SOME HAEMATOLOGICAL PARAMETERS IN STREPTOZOTOCIN-INDUCED DIABETIC RATS TREATED WITH AQUEOUS AND ETHANOLIC EXTRACTS OF MORUS MESOZYGIA LINN. STAPF., LEAVES
The levels of certain inflammatory cytokines are often higher in people with type 2 diabetes. Pro-inflammatory cytokines are the initiators of inflammation that begin the processes of beta cell apoptosis due to insulin r...
ASSESSMENT OF NEUROBEHAVIOURAL PROPERTY OF ETHANOLIC EXTRACTS OF CULCASIA SCADEN AND ITS EFFECT ON HISTOARCHITECTURE OF TEMPORAL LOBE WISTAR RATS
Culcasia scaden is used traditional for the treatment of various disease conditions. This study was carried out to investigate the neurohavioural properties of the ethanolic leaf extract and its effect on the histoarchit...